Proton, Fluorine and X: Practical Aspects and Real Life Applications

In this webinar, Ron Crouch (JEOL) outlines the successful use of isotope shifts in the correct assignment of perfluoro substances. The second participant is Dave Russell (Genentech), who explores the use of the 3-channel HFX-NMR system in drug discovery.

This webinar covers:

• The opportunities and challenges that Fluorine (19F) NMR analysis presents.
• How invaluable the JEOL HFX probe is as a tool for such measurements. 

Presenter Profiles 

David Russell is a structure elucidation scientist with 30 years of experience in the pharmaceutical industry. 

Ron joined Burroughs Welcome Pharmaceuticals after obtaining his degree from Elon University. At Burroughs Welcome Pharmaceuticals, Ron worked closely with many other world-class scientists, including Noble Prize winner Gertrude Elion. 

Ron worked closely with Gary Martin for the last nine years of his work at Burroughs. After this, Ron left the pharmaceutical industry to focus more closely on NMR by taking a role as R&D Manager with Nalorac Corp, followed by many years with Varian NMR in Applications until Agilent NMR’S decline. Ron has worked closely with JEOL USA on NMR ever since. 

This information has been sourced, reviewed and adapted from materials provided by JEOL USA, Inc.

For more information on this source, please visit JEOL USA, Inc.